Statistical analysis uncovered a correlation between NELL1 expression and established risk factors for RMS, such as alveolar histology and positive fusion status; patients with those characteristics have, in fact, high levels of NELL1 just as do patients with advanced tumor stages. The gene discussed is NELL1; the disease is neoplasm.